Hangzhou Diagens Biotechnology Co., Ltd.

Diagens Launches DoctorBench, Setting a New Global Benchmark for Real-World Clinical Performance in Medical Foundation Models

HONG KONG, Apr 30, 2026 - (ACN Newswire) - Hangzhou Diagens Biotechnology Co., Ltd. (2526.HK, “Diagens”) today officially launched DoctorBench, a medical AI evaluation platform, and unveiled its inaugural global medical foundation model leaderboard in Hong Kong. WiseDiag Technology’s WiseDiag- ...

01.05.2026 | Pharma